PMC:7696151 / 90187-90454
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2684 | 104-107 | Chemical | denotes | DXC | MESH:D004318 |
| 2685 | 178-181 | Chemical | denotes | DXC | MESH:D004318 |
| 2686 | 206-209 | Chemical | denotes | HCQ | MESH:D006886 |
| 2713 | 58-67 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T574 | 0-267 | Sentence | denotes | Besides, it can be said that while the acute phase of the infection can be treated with only 200 mg/day DXC, the chronic phase is more difficult to treat and therapy with 100 mg DXC twice daily with 200 mg HCQ three times daily for 18–24 months was recommended [146]. |